Emerging roles of TBK1 in cancer immunobiology

被引：8

作者：

Miranda, Alex ^{[1
,2
]}

Shirley, Carl A. ^{[1
]}

Jenkins, Russell W. ^{[1
,2
]}

机构：

[1] Harvard Med Sch, Massachusetts Gen Hosp, Mass Gen Canc Ctr, Krantz Family Ctr Canc Res,Dept Med, Boston, MA 02114 USA

[2] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA

来源：

TRENDS IN CANCER | 2024年 / 10卷 / 06期

关键词：

IKK-EPSILON; ACTIVATION; RESISTANCE; CELLS; TANK; IMMUNOTHERAPY; PATHWAY; DRIVEN; INFLAMMATION; HOMEOSTASIS;

D O I：

10.1016/j.trecan.2024.02.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TANK-binding kinase 1 (TBK1) is a versatile serine/threonine protein kinase with established roles in innate immunity, metabolism, autophagy, cell death, and inflammation. While best known for its role in regulating innate immunity, TBK1 has emerged as a cancer cell-intrinsic immune evasion gene by virtue of its role in modulating cellular responses to inflammatory signals emanating from the immune system. Beyond its effect on cancer cells, TBK1 appears to regulate lymphoid and myeloid cells in the tumor immune microenvironment. In this review, we detail recent advances in our understanding of the tumor-intrinsic and -extrinsic roles and regulation of TBK1 in tumor immunity.

引用

页码：531 / 540

页数：10

共 77 条

[1] EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis [J].

Ardito, Christine M. ;

Gruener, Barbara M. ;

Takeuchi, Kenneth K. ;

Lubeseder-Martellato, Clara ;

Teichmann, Nicole ;

Mazur, Pawel K. ;

DelGiorno, Kathleen E. ;

Carpenter, Eileen S. ;

Halbrook, Christopher J. ;

Hall, Jason C. ;

Pal, Debjani ;

Briel, Thomas ;

Herner, Alexander ;

Trajkovic-Arsic, Marija ;

Sipos, Bence ;

Liou, Geou-Yarh ;

Storz, Peter ;

Murray, Nicole R. ;

Threadgill, David W. ;

Sibilia, Maria ;

Washington, M. Kay ;

Wilson, Carole L. ;

Schmid, Roland M. ;

Raines, Elaine W. ;

Crawford, Howard C. ;

Siveke, Jens T. .

CANCER CELL, 2012, 22 (03) :304-317

[2] TBK1 Activation by VHL Loss in Renal Cell Carcinoma: A Novel HIF-Independent Vulnerability [J].

Bakouny, Ziad ;

Barbie, David A. .

CANCER DISCOVERY, 2020, 10 (03) :348-350

[3] Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 [J].

Barbie, David A. ;

Tamayo, Pablo ;

Boehm, Jesse S. ;

Kim, So Young ;

Moody, Susan E. ;

Dunn, Ian F. ;

Schinzel, Anna C. ;

Sandy, Peter ;

Meylan, Etienne ;

Scholl, Claudia ;

Froehling, Stefan ;

Chan, Edmond M. ;

Sos, Martin L. ;

Michel, Kathrin ;

Mermel, Craig ;

Silver, Serena J. ;

Weir, Barbara A. ;

Reiling, Jan H. ;

Sheng, Qing ;

Gupta, Piyush B. ;

Wadlow, Raymond C. ;

Le, Hanh ;

Hoersch, Sebastian ;

Wittner, Ben S. ;

Ramaswamy, Sridhar ;

Livingston, David M. ;

Sabatini, David M. ;

Meyerson, Matthew ;

Thomas, Roman K. ;

Lander, Eric S. ;

Mesirov, Jill P. ;

Root, David E. ;

Gilliland, D. Gary ;

Jacks, Tyler ;

Hahn, William C. .

NATURE, 2009, 462 (7269) :108-U122

[4] Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-κB-dependent gene transcription [J].

Bonnard, M ;

Mirtsos, C ;

Suzuki, S ;

Graham, K ;

Huang, JN ;

Ng, M ;

Itié, A ;

Wakeham, A ;

Shahinian, A ;

Henzel, WJ ;

Elia, AJ ;

Shillinglaw, W ;

Mak, TW ;

Cao, ZD ;

Yeh, WC .

EMBO JOURNAL, 2000, 19 (18) :4976-4985

[5] RaIB GTPase-mediated activation of the IκB family kinase TBK1 couples innate immune signaling to tumor cell survival [J].

Chien, Yuchen ;

Kim, Sungchan ;

Bumeister, Ron ;

Loo, Yueh-Ming ;

Kwon, Sung Won ;

Johnson, Cynthia L. ;

Balakireva, Mirey G. ;

Romeo, Yves ;

Kopelovich, Levy ;

Gale, Michael, Jr. ;

Yeaman, Charles ;

Camonis, Jacques H. ;

Zhao, Yingming ;

White, Michael A. .

CELL, 2006, 127 (01) :157-170

[6] TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer [J].

Cooper, Jonathan M. ;

Ou, Yi-Hung ;

McMillan, Elizabeth A. ;

Vaden, Rachel M. ;

Zaman, Aubhishek ;

Bodemann, Brian O. ;

Makkar, Gurbani ;

Posner, Bruce A. ;

White, Michael A. .

CANCER RESEARCH, 2017, 77 (18) :5077-5094

[7] Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma [J].

Eskiocak, Banu ;

McMillan, Elizabeth A. ;

Mendiratta, Saurabh ;

Kollipara, Rahul K. ;

Zhang, Hailei ;

Humphries, Caroline G. ;

Wang, Changguang ;

Garcia-Rodriguez, Jose ;

Ding, Ming ;

Zaman, Aubhishek ;

Rosales, Tracy I. ;

Eskiocak, Ugur ;

Smith, Michael P. ;

Sudderth, Jessica ;

Komurov, Kakajan ;

Deberardinis, Ralph J. ;

Wellbrock, Claudia ;

Davies, Michael A. ;

Wargo, Jennifer A. ;

Yu, Yonghao ;

De Brabander, Jef K. ;

Williams, Noelle S. ;

Chin, Lynda ;

Rizos, Helen ;

Long, Georgina V. ;

Kittler, Ralf ;

White, Michael A. .

CANCER DISCOVERY, 2017, 7 (08) :832-851

[8] MAVS activates TBK1 and IKKε through TRAFs in NEMO dependent and independent manner [J].

Fang, Run ;

Jiang, Qifei ;

Zhou, Xiang ;

Wang, Chenguang ;

Guan, Yukun ;

Tao, Jianli ;

Xi, Jianzhong ;

Feng, Ji-Ming ;

Jiang, Zhengfan .

PLOS PATHOGENS, 2017, 13 (11)

[9] TBK1 and IKKe act like an OFF switch to limit NLRP3 inflammasome pathway activation [J].

Fischer, Fabian A. ;

Mies, Linda F. M. ;

Nizami, Sohaib ;

Pantazi, Eirini ;

Danielli, Sara ;

Demarco, Benjamin ;

Ohlmeyer, Michael ;

Lee, Michelle Sue Jann ;

Coban, Cevayir ;

Kagan, Jonathan C. ;

Di Daniel, Elena ;

Bezbradica, Jelena S. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (38)

[10] IKKε and TBK1 are essential components of the IRF3 signaling pathway [J].

Fitzgerald, KA ;

McWhirter, SM ;

Faia, KL ;

Rowe, DC ;

Latz, E ;

Golenbock, DT ;

Coyle, AJ ;

Liao, SM ;

Maniatis, T .

NATURE IMMUNOLOGY, 2003, 4 (05) :491-496

← 1 2 3 4 5 6 7 8 →